This contract expires in 24 days (Jun 30, 2026).

Browse related active opportunities

FIRM FIXED PRICE

WESTAT, INC. - CREUTZFELDT-JAKOB DISEASE SURVEILLANCE IN RECIPIENTS OF HUMAN GROWTH HORMONE

PIID: 75N94023F00090Solicitation ID: 75N94023Q000559
Signed Date: Jan 23, 2026Effective Date: Jul 1, 2023End Date: Closes in 24 days
Award $
$778K
Vendor
WESTAT, INC.
NAICS
541611
Signed Date
Jan 23, 2026

Key Details

Dollars Obligated
$777,523
Base & All Options
Awarding Sub-Agency
National Institutes of Health
Product Service Code
B529 - SPECIAL STUDIES/ANALYSIS- SCIENTIFIC DATA
Extent Competed
FULL AND OPEN COMPETITION
Number of Offers
1
Place of Performance
BETHESDA, MD, 208171801, CD-MD-08

Description

CREUTZFELDT-JAKOB DISEASE SURVEILLANCE IN RECIPIENTS OF HUMAN GROWTH HORMONE

Context & Analysis

On Jan 23, 2026, Department of Health and Human Services obligated $777,523 to WESTAT, INC. for creutzfeldt-jakob disease surveillance in recipients of human growth hormone. The award is classified under NAICS 541611 — ADMINISTRATIVE MANAGEMENT AND GENERAL MANAGEMENT CONSULTING SERVICES and issued as a firm fixed price contract. Competition extent: full and open competition with 1 offer received. Performance is located in BETHESDA, MD. The contract is scheduled through Jun 30, 2026 — approximately 1 month remaining. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541611 — related awards are listed below.

Contractor Information

Contractor: WESTAT, INC.
UEI: NVUWAFWQ57S5
CAGE Code: 1D075
Location: ROCKVILLE, MD

Stay Updated

Get notified about new opportunities matching your interests.

Related